Article: Ixazomib significantly delays disease progression in patients with relpased/refractory multiple myeloma

€3.03

SKU: product-article-17984 Category: General

Description
Reviews (0)

Description

Ixazomib significantly delays disease progression in patients with relpased/refractory multiple myeloma

Reviews

There are no reviews yet.

Be the first to review “Article: Ixazomib significantly delays disease progression in patients with relpased/refractory multiple myeloma”

You must be logged in to post a review.

Top

Article: Ixazomib significantly delays disease progression in patients with relpased/refractory multiple myeloma

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in melanoma

Article: Highlights in gynaecological cancers

Article: Highlights in squamous cell carcinoma of the head and neck